LI
FLXN

Leap Investments’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Leap Investments’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,200
Closed -$211K – 651
2019
Q4 		$211K Buy
+10,200
New +$172K 0.1% 314

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Leap Investments's FLXN Position: Q1 2020 in Review

Leap Investments sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 10,200 shares — an estimated $211K sold.

Leap Investments first reported a position in FLXN in Q4 2019 and held it in 1 quarter. The position peaked at $211K in Q4 2019. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

  • Leap Investments reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Leap Investments sold 10,200 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $211K.
  • Leap Investments first reported a position in Flexion Therapeutics, Inc. in Q4 2019 and held it in 1 quarter.
  • Leap Investments's Flexion Therapeutics, Inc. position peaked at $211K in Q4 2019.
  • 123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.